These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 17909367)

  • 1. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases.
    Curtis LH; Hammill BG; Eisenstein EL; Kramer JM; Anstrom KJ
    Med Care; 2007 Oct; 45(10 Supl 2):S103-7. PubMed ID: 17909367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
    Pullenayegum EM; Willan AR
    Stat Med; 2007 Jul; 26(17):3274-99. PubMed ID: 17309112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighted rank regression for clustered data analysis.
    Wang YG; Zhao Y
    Biometrics; 2008 Mar; 64(1):39-45. PubMed ID: 17608784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. About an adaptively weighted Kaplan-Meier estimate.
    Plante JF
    Lifetime Data Anal; 2009 Sep; 15(3):295-315. PubMed ID: 19533346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder.
    Williamson EJ; Forbes A; Wolfe R
    Stat Med; 2012 Dec; 31(30):4382-400. PubMed ID: 23086504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dynamic treatment regimes via inverse probability weighting.
    Hernán MA; Lanoy E; Costagliola D; Robins JM
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; Zhu Z; Rassen JA; Seeger JD; Schneeweiss S
    Stat Med; 2015 Feb; 34(5):753-81. PubMed ID: 25488047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted learning in real-world comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; van der Laan MJ
    Stat Med; 2014 Jun; 33(14):2480-520. PubMed ID: 24535915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivatives.
    Meister R; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):31-5. PubMed ID: 18620043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.
    Austin PC
    Stat Med; 2008 May; 27(12):2037-49. PubMed ID: 18038446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kaplan-Meier analysis].
    Tripepi G; Catalano F
    G Ital Nefrol; 2004; 21(6):540-6. PubMed ID: 15593021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.
    Fang G; Brooks JM; Chrischilles EA
    Am J Epidemiol; 2012 Jan; 175(1):60-5. PubMed ID: 22085626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach.
    Qu Y; Lipkovich I
    Stat Med; 2009 Apr; 28(9):1402-14. PubMed ID: 19222021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic differences in treatment effect estimates between propensity score methods and logistic regression.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
    Segal JB; Griswold M; Achy-Brou A; Herbert R; Bass EB; Dy SM; Millman AE; Wu AW; Frangakis CE
    Med Care; 2007 Oct; 45(10 Supl 2):S149-57. PubMed ID: 17909374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials: odds ratios and multiple regression models--why and how to assess them.
    Sobh M; Cleophas TJ; Hadj-Chaib A; Zwinderman AH
    Am J Ther; 2008; 15(1):44-52. PubMed ID: 18223353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for deriving pesticide aquatic life criteria.
    TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
    Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statistical models and evaluation of observation studies].
    Koch A; Windeler J
    Med Klin (Munich); 2000 May; 95(1 Spec No):61-7. PubMed ID: 10851850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concept of the marginally matched subject in propensity-score matched analyses.
    Austin PC; Lee DS
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):469-82. PubMed ID: 19319923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.